Subscribe To
Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc
– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...
November 2, 2023, 11:30 am
Oric pharmaceuticals to present initial phase 1b clinical data for oric 114 in egfr/her2 exon 20 mutated nsclc at the european society of medical oncology (esmo) congress 2023
Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and p...
October 17, 2023, 4:30 pm
Astrazeneca's (azn) tagrisso combo gets fda's priority review
The FDA accepts and grants priority review to AstraZeneca's (AZN) sNDA, seeking approval of Tagrisso combined with chemotherapy as a first-line treatm...
October 17, 2023, 12:46 pm
J&j's (jnj) rybrevant combo meets primary goal in nsclc study
J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-...
October 2, 2023, 12:01 pm
Theseus pharmaceuticals: picking up the pieces after a lead failure
Theseus Pharmaceuticals experienced significant losses after discontinuing its lead program, leaving it with a market cap of half of its current asset...
September 29, 2023, 7:35 am
Dyne therapeutics: muscle disease oligo therapy developer in early stages
Dyne Therapeutics is developing treatments for genetically driven muscle diseases, focusing on Myotonic Dystrophy Type 1 (DM1) and Duchenne Muscular D...
September 10, 2023, 5:25 am
Pfizer says updated covid shot generated strong reaction vs new variant in mice
Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the hi...
September 6, 2023, 2:10 pm
Moderna vaccine effective against latest covid strain
Moderna Therapeutics Inc (NASDAQ:MRNA) has told investors that its revised Covid vaccine appears effective against the BA.2.86 subvariant, a highly ...
September 6, 2023, 9:26 am
Nuvectis: early stage company that's low on cash
Nuvectis is developing precision medicines for cancer patients, with lead asset NXP800 targeting ARID1a-mutate...
September 6, 2023, 8:03 am
Moderna's updated covid vaccine is effective against pirola variant—as concern over new strain grows
Experts are worried the highly mutated variant, a relative of omicron formally called BA.2.86, could tr...
September 6, 2023, 7:03 am
Moderna says updated covid vaccine is effective against newer variant
Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-...
September 6, 2023, 7:03 am
Moderna says updated covid vaccine was effective against highly mutated ba.2.86 variant in trial
Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA....
September 6, 2023, 7:02 am
Astrazeneca's (azn) lynparza gets expanded use nod in japan
AstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to treat adult patients with BRCA-...
August 25, 2023, 1:32 pm
Mirati (mrtx) down 7% on chmp's opinion on krazati filing
Per the CHMP, Mirati's (MRTX) regulatory filing for Krazati in KRASG12C mutated NSCLC does not fulfill ...
July 24, 2023, 1:05 pm
Diving into day one biopharmaceuticals
Shares of precision oncology concern Day One Biopharmaceuticals, Inc. are down over 50% from their 2023 high as Novartis' combination therapy received...
July 23, 2023, 4:43 am
Fda expands pfizer's (pfe) talzenna label in prostate cancer
Following FDA's label-expansion approval, Pfizer's (PFE) Talzenna is the first PARP inhibitor approved in combination with existing standard of care f...
June 21, 2023, 3:34 pm
Ptc therapeutics huntington's disease drug shows promise in mid-stage trial
PTC Therapeutics Inc said on Wednesday its experimental Huntington's disease drug lowered mutated prote...
June 21, 2023, 7:33 am
Fda advisers endorse updating covid vaccines to target latest omicron strain
Today's vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by
June 15, 2023, 4:49 pm
Esr1 mutated metastatic breast cancer diagnostics market to hit us$ 185 million by 2033 and grow at a cagr of 11% during forecast | future market insights, inc.
The ESR1-mutated metastatic breast cancer market is expected to surge in the coming years due to the ri...
June 5, 2023, 2:30 pm
Astrazeneca drug combo gets us nod to treat a type of prostate cancer
AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the treatment o...
June 1, 2023, 2:50 am